Page last updated: 2024-10-26

etidronate and Obstructive Lung Diseases

etidronate has been researched along with Obstructive Lung Diseases in 2 studies

Etidronic Acid: A diphosphonate which affects calcium metabolism. It inhibits ectopic calcification and slows down bone resorption and bone turnover.
etidronic acid : A 1,1-bis(phosphonic acid) that is (ethane-1,1-diyl)bis(phosphonic acid) having a hydroxy substituent at the 1-position. It inhibits the formation, growth, and dissolution of hydroxyapatite crystals by chemisorption to calcium phosphate surfaces.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Goldstein, MF1
Fallon, JJ1
Harning, R1
Palange, P1
Carlone, S1
Serra, P1
Mannix, ET1
Manfredi, F1
Farber, MO1

Reviews

1 review available for etidronate and Obstructive Lung Diseases

ArticleYear
Chronic glucocorticoid therapy-induced osteoporosis in patients with obstructive lung disease.
    Chest, 1999, Volume: 116, Issue:6

    Topics: Administration, Inhalation; Administration, Oral; Adult; Alendronate; Asthma; Bone Density; Bone Rem

1999

Trials

1 trial available for etidronate and Obstructive Lung Diseases

ArticleYear
Pharmacologic elevation of blood inorganic phosphate in hypoxemic patients with COPD.
    Chest, 1991, Volume: 100, Issue:1

    Topics: 2,3-Diphosphoglycerate; Aged; Carboxyhemoglobin; Diphosphoglyceric Acids; Etidronic Acid; Exercise T

1991